Llwytho...
Recent advances in the understanding and treatment of acute myeloid leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease that has a poor prognosis. Recent advances in genomics and molecular biology have led to a greatly improved understanding of the disease. Until 2017, there had been no new drugs approved for AML in decades. Here, we r...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | F1000Res |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
F1000 Research Limited
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6081972/ https://ncbi.nlm.nih.gov/pubmed/30135719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.14116.1 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|